内布拉斯加大学寻求以8亿美元收购克拉克森在内布拉斯加医学公司的股份，待1月9日投票。 University of Nebraska seeks $800M deal to buy Clarkson’s stake in Nebraska Medicine, pending Jan. 9 vote.

内布拉斯加州大学执政官理事会将考虑一项8亿美元的协议,以结束克拉克森地区卫生局50%的内布拉斯加州医学股份,将全部控制权移交给大学。 The University of Nebraska Board of Regents will consider a $800 million deal to end Clarkson Regional Health Services’ 50% stake in Nebraska Medicine, transferring full control to the university. NU将为Clarkson的份额支付5亿美元,为其财产支付3亿美元,而Clarkson计划向UNMC捐赠2亿美元。 NU would pay $500 million for Clarkson’s share and $300 million for its property, while Clarkson plans a $200 million donation to UNMC. 此举旨在改善协调性，但遭到内布拉斯加医学部的反对，他们称之为“州政府接管”，并批评缺乏协商。 The move aims to improve alignment but faces opposition from Nebraska Medicine, which calls it a "state takeover" and criticizes lack of consultation. 尽管发生了这些变化,内布拉斯加医学将继续独立运作,对工作人员或服务没有直接影响。 Despite the change, Nebraska Medicine will continue operating independently with no immediate impact on staff or services. 该决定有待1月9日第9次会议作出决定。 The decision is pending at a Jan. 9 meeting.